Insider Selling: Sotera Health (NASDAQ:SHC) Insider Sells $2,826,000.00 in Stock

Sotera Health Company (NASDAQ:SHCGet Free Report) insider Michael Rutz sold 150,000 shares of the company’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $18.84, for a total value of $2,826,000.00. Following the completion of the transaction, the insider owned 334,279 shares in the company, valued at $6,297,816.36. This represents a 30.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Sotera Health Price Performance

SHC stock opened at $19.02 on Friday. The business has a fifty day moving average of $17.42 and a two-hundred day moving average of $16.32. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. The stock has a market cap of $5.43 billion, a price-to-earnings ratio of 33.37 and a beta of 1.77. Sotera Health Company has a 52-week low of $13.09 and a 52-week high of $19.85.

Sotera Health (NASDAQ:SHCGet Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. The company had revenue of $321.38 million for the quarter, compared to the consensus estimate of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The company’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.20 earnings per share. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, research analysts anticipate that Sotera Health Company will post 0.87 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have weighed in on SHC. UBS Group set a $19.00 target price on shares of Sotera Health in a research note on Wednesday, June 24th. Barclays upped their price objective on shares of Sotera Health from $19.00 to $22.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. Piper Sandler reaffirmed an “overweight” rating and set a $25.00 price objective (up from $22.00) on shares of Sotera Health in a research report on Friday, August 7th. Weiss Ratings upgraded shares of Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday. Finally, The Goldman Sachs Group initiated coverage on Sotera Health in a research report on Friday, June 5th. They issued a “buy” rating and a $20.00 target price on the stock. Eight analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $21.50.

Check Out Our Latest Stock Report on Sotera Health

Hedge Funds Weigh In On Sotera Health

Several institutional investors have recently bought and sold shares of SHC. SaddleRock Capital Management LLC acquired a new stake in shares of Sotera Health during the second quarter worth about $5,441,000. Sanctuary Advisors LLC acquired a new position in shares of Sotera Health in the second quarter valued at approximately $278,000. Two Seas Capital LP acquired a new position in shares of Sotera Health in the second quarter valued at approximately $103,590,000. Evolve Private Wealth LLC purchased a new stake in Sotera Health during the 2nd quarter worth approximately $207,000. Finally, Ieq Capital LLC purchased a new stake in Sotera Health during the 2nd quarter worth approximately $1,747,000. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Company Profile

(Get Free Report)

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

Read More

Insider Buying and Selling by Quarter for Sotera Health (NASDAQ:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.